Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03968393 · ClinicalTrials.gov registry record · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
A Phase 4 study of Stroke and Atrial Fibrillation, sponsored by Population Health Research Institute.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 2,270
- Enrollment target
- 20
- Study locations
NCT03968393: Recruiting Phase 4 study of Stroke and Atrial Fibrillation, sponsored by Population Health Research Institute.
NCT03968393 is a Phase 4 study of Stroke and Atrial Fibrillation that is actively recruiting participants, run by Population Health Research Institute. The registered enrollment target is 2,270 participants, below the 12,011-participant average among 454 other Stroke trials with a reported enrollment target (81% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03968393, a Phase 4 study of Stroke and Atrial Fibrillation, is actively recruiting participants, sponsored by Population Health Research Institute.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 2,270 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.
Conditions Studied
Interventions
- DRUG Non-vitamin K oral anticoagulant (NOAC)
Study Locations (20)
New South Wales
- Bankstown Hospital - Bankstown
- Royal Prince Alfred Hospital - Camperdown
- Concord Repatriation General Hospital - Concord
- Liverpool Hospital - Liverpool
- John Hunter Hospital - Newcastle
- Westmead Hospital - Westmead
Other
- Hospital Municipal Chivilcoy - Chivilcoy
- Sanatorio Cisma - San Miguel de Tucumán
- Hospital Privado de Rosario - Santa Fe
Queensland
- Sunshine Coast Hospital and Health Service - Birtinya
- Royal Brisbane and Women's Hospital - Herston
- Redcliffe Hospital - Redcliffe
Santa Fe Province
- Instituto de Investigaciones Clinicas Rosario - Rosario
- Instituto Cardiovascular de Rosario - Rosario
California
- Cedars-Sinai Medical Center - Los Angeles
Texas
- Mcgovern Medical School at University of Texas - Houston
Buenos Aires
- Clinica Coronel Suarez - Coronel Suárez
Tucumán Province
- Centro Integral de Arritmias de Tucuman (CIAT) - San Miguel de Tucumán
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,270 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2028-12 |
| Phase | Phase 4 |
What NCT03968393 shows while recruiting
NCT03968393 is an interventional study that assigns participants to a tested intervention. Its 2,270 participants enrollment target places it among the larger protocols in the corpus, below the 12,011-participant average among 454 other Stroke trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Non-vitamin K oral anticoagulant (NOAC) is the first listed.
NCT03968393 names 20 study sites across 10 states, led by New South Wales, Other, Queensland.
Frequently Asked Questions
What is clinical trial NCT03968393 about?
NCT03968393 is a clinical study titled "Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress". Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.
What is the current status of trial NCT03968393?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 2,270 participants. The study started on 2019-06-14. Estimated completion is 2028-12.
What conditions does trial NCT03968393 study?
This clinical trial studies the following conditions: Stroke, Atrial Fibrillation.
What interventions are being tested in trial NCT03968393?
The interventions under investigation include: Non-vitamin K oral anticoagulant (NOAC) (DRUG).
Who is sponsoring clinical trial NCT03968393?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03968393 being conducted?
This trial has 20 study locations across California, Texas, Buenos Aires, Santa Fe Province, Tucumán Province. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03968393's enrollment target sits among peer trials
2,270 25th of 454 higher than 430 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
Xeomin® and Gait Related Mobility After Stroke
RECRUITING · Phase 4
-
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
ACTIVE NOT RECRUITING · Phase 4
-
SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke
COMPLETED · Phase 4
-
Gait Training For Acute Stroke: Functional Neuromuscular Stimulation (FNS) and Weight Supported Treadmill Training
COMPLETED · Phase 4
-
Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI